| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/JNR.21656 |
| P698 | PubMed publication ID | 18338801 |
| P50 | author | Eng-King Tan | Q67189690 |
| P2093 | author name string | Yi Wei Lu | |
| P433 | issue | 9 | |
| P921 | main subject | molecular biology | Q7202 |
| Parkinson's disease | Q11085 | ||
| P304 | page(s) | 1895-1901 | |
| P577 | publication date | 2008-07-01 | |
| P1433 | published in | Journal of Neuroscience Research | Q6295654 |
| P1476 | title | Molecular biology changes associated with LRRK2 mutations in Parkinson's disease | |
| P478 | volume | 86 |
| Q46818568 | Association of GWAS loci with PD in China |
| Q37376117 | Cell death pathways in Parkinson's disease: proximal triggers, distal effectors, and final steps |
| Q37810992 | Development of Parkinson’s disease biomarkers |
| Q37583402 | Genetic insights into sporadic Parkinson's disease pathogenesis |
| Q64958593 | LRRK2 R1628P increases risk of Parkinson's disease: replication evidence |
| Q39263032 | Targeting LRRK2 in Parkinson's disease: an update on recent developments |
| Q38160939 | Targeting leucine-rich repeat kinase 2 in Parkinson's disease |
| Q37597933 | The LRRK2 G2019S mutation as the cause of Parkinson's disease in Ashkenazi Jews |
| Q30438387 | Wild-type LRRK2 but not its mutant attenuates stress-induced cell death via ERK pathway |
Search more.